Aquestive Therapeutics CEO Daniel Barber disposes of 25,000 shares worth $120,487.50 - AQST News | RalliesAquestive Therapeutics CEO Daniel Barber disposes of 25,000 shares worth $120,487.50
A
AQST• CEO sells shares in weighted-average transaction
- Aquestive Therapeutics President and CEO Daniel Barber sold 25,000 common shares on Sept. 15, 2026.
- The sale was priced at $4.82 per share on a weighted-average basis.
- Direct holdings fell to 652,317 common shares following the transaction.
•
